Predictive Oncology (POAI) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

Predictive Oncology Revenue Highlights

Latest Revenue (Y)

$1.78M

Latest Revenue (Q)

$345.69K

Main Segment (Y)

Pittsburgh

Main Geography (Y)

Skyline

Predictive Oncology Revenue by Period

Predictive Oncology Revenue by Year

Date	Revenue	Change
2023-12-31	$1.78M	18.24%
2022-12-31	$1.51M	5.97%
2021-12-31	$1.42M	13.45%
2020-12-31	$1.25M	-11.28%
2019-12-31	$1.41M	-0.01%
2018-12-31	$1.41M	115.57%
2017-12-31	$654.84K	43.45%
2016-12-31	$456.50K	-30.24%
2015-12-31	$654.35K	-31.23%
2014-12-31	$951.56K	103.27%
2013-12-31	$468.13K	147.98%
2012-12-31	$188.77K	95.34%
2011-12-31	$96.64K	33454.51%
2010-12-31	$288.00	-98.17%
2009-12-31	$15.74K	100.00%
2008-12-31	-	-

Predictive Oncology generated $1.78M in revenue during NA 2023, up 18.24% compared to the previous quarter, and up 126.10% compared to the same period a year ago.

Predictive Oncology Revenue by Quarter

Date	Revenue	Change
2024-09-30	$345.69K	24.03%
2024-06-30	$278.72K	-33.58%
2024-03-31	$419.65K	25.26%
2023-12-31	$335.03K	-53.15%
2023-09-30	$715.06K	45.90%
2023-06-30	$490.11K	104.30%
2023-03-31	$239.90K	-34.00%
2022-12-31	$363.47K	-20.26%
2022-09-30	$455.83K	22.67%
2022-06-30	$371.59K	18.13%
2022-03-31	$314.57K	-33.98%
2021-12-31	$476.49K	51.91%
2021-09-30	$313.66K	-10.43%
2021-06-30	$350.21K	24.93%
2021-03-31	$280.32K	-4.59%
2020-12-31	$293.79K	-38.89%
2020-09-30	$480.76K	163.02%
2020-06-30	$182.78K	-38.03%
2020-03-31	$294.94K	-15.12%
2019-12-31	$347.48K	-33.52%
2019-09-30	$522.70K	82.66%
2019-06-30	$286.15K	12.11%
2019-03-31	$255.24K	-18.07%
2018-12-31	$311.55K	-5.57%
2018-09-30	$329.93K	-7.99%
2018-06-30	$358.59K	-12.88%
2018-03-31	$411.59K	86.82%
2017-12-31	$220.31K	44.43%
2017-09-30	$152.53K	42.79%
2017-06-30	$106.82K	-39.02%
2017-03-31	$175.17K	25.51%
2016-12-31	$139.56K	3.68%
2016-09-30	$134.60K	57.58%
2016-06-30	$85.42K	-11.85%
2016-03-31	$96.91K	-47.13%
2015-12-31	$183.28K	113.63%
2015-09-30	$85.79K	-63.34%
2015-06-30	$234.01K	54.69%
2015-03-31	$151.27K	-8.76%
2014-12-31	$165.79K	-58.27%
2014-09-30	$397.25K	24.81%
2014-06-30	$318.29K	353.28%
2014-03-31	$70.22K	-14.06%
2013-12-31	$81.71K	-24.23%
2013-09-30	$107.83K	-28.52%
2013-06-30	$150.86K	18.11%
2013-03-31	$127.73K	42.61%
2012-12-31	$89.56K	73.52%
2012-09-30	$51.62K	106.79%
2012-06-30	$24.96K	10.27%
2012-03-31	$22.64K	-69.41%
2011-12-31	$74.00K	265.17%
2011-09-30	$20.26K	753.58%
2011-06-30	$2.37K	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	-100.00%
2010-03-31	$288.00	100.00%
2009-12-31	-	100.00%
2009-09-30	-	-100.00%
2009-06-30	$15.74K	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	-

Predictive Oncology generated $345.69K in revenue during Q3 2024, up 24.03% compared to the previous quarter, and up 70.53% compared to the same period a year ago.

Predictive Oncology Revenue Breakdown

Predictive Oncology Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Pittsburgh	$492.60K	-	-	-	-
zPREDICTA	-	$352.38K	$90.00	-	-
Soluble	-	$82.30K	$233.29K	$2.87K	-
Skyline	-	$1.06M	$1.17M	$1.19M	-
Helomics Segment	-	$6.40K	$13.37K	$64.19K	$48.45K
International	-	-	-	-	$88.07K
Domestic	-	-	-	-	$1.28M

Predictive Oncology's latest annual revenue breakdown by segment (product or service), as of Dec 23: Pittsburgh (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Pittsburgh	$3.91K	$67.25K	$4.86K	$51.03K	$417.10K	$13.84K	$10.63K	-	-	-	-	-	-	-	-	-	-	-	-	-
Soluble	-	-	-	-	-	-	-	$17.72K	$29.44K	$22.23K	$12.92K	$156.65K	$27.65K	$34.91K	$14.07K	-	-	-	-	-
Helomics Segment	-	-	-	-	-	-	-	$854.00	$1.82K	$84.00	$3.64K	$2.05K	$2.16K	$7.16K	$1.99K	$30.31K	$9.70K	$9.05K	$15.13K	-
Skyline	-	-	-	-	-	-	-	$253.62K	$253.75K	$276.85K	$279.27K	$316.75K	$282.68K	$306.14K	$264.25K	$260.61K	$471.05K	-	-	-
zPREDICTA	-	-	-	-	-	-	-	$91.28K	$170.82K	$71.94K	$18.34K	-	-	-	-	-	-	-	-	-
Domestic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$173.74K	$279.81K	$340.43K
International	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$11.02K

Predictive Oncology's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Pittsburgh (100.00%).

Predictive Oncology Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 22	Dec 19
zPREDICTA	$352.38K	-
Helomics Segment	$6.40K	-
Skyline	$1.06M	-
Soluble	$82.30K	-
Domestic	-	$1.28M

Predictive Oncology's latest annual revenue breakdown by geography, as of Dec 22: Skyline (70.68%), zPREDICTA (23.42%), Soluble (5.47%), and Helomics Segment (0.43%).

Quarterly Revenue by Country

Country	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18
Domestic	$173.74K	$279.81K	$340.43K	$455.88K	$259.08K	$219.66K	-	-
Non-US	-	-	-	-	-	-	$4.20K	$3.18K

Predictive Oncology's latest quarterly revenue breakdown by geography, as of Jun 20: Domestic (100.00%).

Predictive Oncology Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ISRG	Intuitive Surgical	$7.12B	$2.04B
PDEX	Pro-Dex	$53.84M	$14.89M
BNGO	Bionano Genomics	$36.12M	$6.07M
DXR	Daxor	$34.59M	$36.35M
ZJYL	Jin Medical	$19.82M	$9.57M
NYXH	Nyxoah	$4.30M	$1.22M
NXGL	NEXGEL	$4.09M	$1.44M
POAI	Predictive Oncology	$1.78M	$345.69K
LUCY	Innovative Eyewear	$1.15M	$253.60M
GCTK	GlucoTrack	-	-
MBOT	Microbot Medical	-	-
STSS	Sharps	-	-

POAI Revenue FAQ

What is Predictive Oncology’s yearly revenue?

Predictive Oncology's yearly revenue for 2023 was $1.78M, representing an increase of 18.24% compared to 2022. The company's yearly revenue for 2022 was $1.51M, representing an increase of 5.97% compared to 2021. POAI's yearly revenue for 2021 was $1.42M, representing an increase of 13.45% compared to 2020.

What is Predictive Oncology’s quarterly revenue?

Predictive Oncology's quarterly revenue for Q3 2024 was $345.69K, a 24.03% increase from the previous quarter (Q2 2024), and a -51.66% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $278.72K, a -33.58% decrease from the previous quarter (Q1 2024), and a -43.13% decrease year-over-year (Q2 2023). POAI's quarterly revenue for Q1 2024 was $419.65K, a 25.26% increase from the previous quarter (Q4 2023), and a 74.93% increase year-over-year (Q1 2023).

What is Predictive Oncology’s revenue growth rate?

Predictive Oncology's revenue growth rate for the last 3 years (2021-2023) was 25.30%, and for the last 5 years (2019-2023) was 26.11%.

What are Predictive Oncology’s revenue streams?

Predictive Oncology's revenue streams in c 23 are Pittsburgh

What is Predictive Oncology’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Predictive Oncology was Pittsburgh. This segment made a revenue of $492.6K, representing 100.00% of the company's total revenue.